ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00312377. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized, Double-Blinded, Multi-Center, Study to Assess the Efficacy of Docetaxel (TAXOTERE™) in Combination With ZD6474 (ZACTIMA™) Versus Docetaxel (TAXOTERE™) With Placebo in Subjects With Locally Advanced or Metastatic NSCLC
Study identification
- NCT ID
- NCT00312377
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Enrollment
- 1,690 participants
Conditions and interventions
Conditions
Interventions
- Docetaxel Drug
- Vandetanib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2006
- Primary completion
- Jul 31, 2008
- Completion
- Feb 28, 2014
- Last update posted
- Sep 29, 2016
2006 – 2014
United States locations
- U.S. sites
- 27
- U.S. states
- 19
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Fullerton | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Northridge | California | — | — |
| Research Site | Colorado Springs | Colorado | — | — |
| Research Site | Norwalk | Connecticut | — | — |
| Research Site | Ocala | Florida | — | — |
| Research Site | Marietta | Georgia | — | — |
| Research Site | Joliet | Illinois | — | — |
| Research Site | Park Ridge | Illinois | — | — |
| Research Site | Hutchinson | Kansas | — | — |
| Research Site | Louisville | Kentucky | — | — |
| Research Site | Boston | Massachusetts | — | — |
| Research Site | Ann Arbor | Michigan | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Henderson | Nevada | — | — |
| Research Site | Albany | New York | — | — |
| Research Site | Armonk | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Durham | North Carolina | — | — |
| Research Site | Hickory | North Carolina | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Ogden | Utah | — | — |
| Research Site | Alexandria | Virginia | — | — |
| Research Site | Salem | Virginia | — | — |
| Research Site | Vancouver | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 129 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00312377, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2016 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00312377 live on ClinicalTrials.gov.